MIXED-WALLED MICROCAPSULES MADE OF CROSS-LINKED PROTEINS AND POLYSACCHARIDES - PREPARATION AND PROPERTIES

被引:24
作者
LEVY, MC
ANDRY, MC
机构
[1] Laboratoire de Pharmacotechnie, URA/CNRS 492, Faculté de Pharmacie, Université de Reims Champagne-Ardenne, Reims Cedex, F51096, 51, rue Cognacq-Jay
关键词
D O I
10.3109/02652049109069560
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Microcapsules were prepared through an interfacial cross-linking process using terephthaloylchloride and applied to mixtures of a protein (human serum albumin or gelatin) and a polysaccharide. Their properties were compared with those of microcapsules prepared from the protein alone. Morphological characteristics of mixed-walled microcapsules were often modified, as seen by light and electron microscopy. Otherwise, they appeared to be more resistant to digestive media: they were gastroresistant, and their degradation time in pancreatin was prolonged upon raising the amount of polysaccharide. Moreover, the lysis time was shown to depend on the nature of the polysaccharide: microcapsules prepared from acidic polysaccharides at pH 9.8 were hydrolyzed faster. Lastly, the resistance increased upon decreasing the polymers/acylchloride ratio, or upon raising the reaction pH. Encapsulation assays were carried out with sodium salicylate, which was incorporated with a high efficiency. Mixed-walled microcapsules allowed a prolonged release of the tracer in vitro. As compared with protein microcapsules, the release profiles of batches prepared with hydroxyethylstarch exhibited only slight modifications of the initial part of the curve, while a significant burst effect was observed with carboxymethylcellulose-containing microcapsules.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 25 条
[11]  
Levy M.-C., Andry M.-C., Microcapsules à propriétés modulables formées de protéines et de polysaccharides coréticulés, Thérapie, 44, pp. 365-369, (1989)
[12]  
Levy M.-C., Andry M.-C., Microcapsules prepared through interfacial cross-linking of starch derivatives, International Journal of Pharmaceutics, 62, pp. 27-35, (1990)
[13]  
Levy M.-C., Andry M.-C., An evaluation of gelatin microcapsules prepared using an interfacial cross-linking process, Life Science Advances, 19, pp. 219-227, (1990)
[14]  
Levy M.-C., Guerin D., Microcapsules préparées par réticulation interfaciale des protéines du lait, Pharmaceutica Acta Helvetiae, 8, pp. 236-240, (1987)
[15]  
Levy M.-C., Rambourg P., Levy J., Potron G., Microencapsulation IV: Cross-linked haemoglobin microcapsules, Journal of Pharmaceutical Sciences, 71, pp. 759-762, (1982)
[16]  
Levy M.-C., Lefebvre S., Rahmouni M., Andry M.-C., Manfait M., FT-IR spectroscopic studies of human serum albumin microcapsules prepared by interfacial cross-linking with terephthaloylchloride: influence of polycondensation pH on spectra and relation with microcapsule morphology and size, Journal of Pharmaceutical Sciences
[17]  
Maulding H.V., Prolonged delivery of peptides by microcapsules, Journal of Controlled Release, 6, pp. 167-176, (1987)
[18]  
Molteni L., Effects of the polysaccharidic carrier on the kinetic fate of drugs linked to dextran and inulin in macromolecular compounds, Optimisation of Drug Delivery, A. Benzon Symposium 17, pp. 286-301, (1982)
[19]  
Ponder E., Ponder R., The interaction of dextran with serumalbumin, Journal of General Physiology, 43, pp. 753-758, (1959)
[20]  
Poznansky M.J., Juliano R.L., Biological approaches to the controlled delivery of drugs: a critical review, Pharmacological Reviews, 36, pp. 277-336, (1984)